Home Coronavirus COVID-19 Johnson & Johnson Covid-19 Vaccine: 66% Effective in Global Trial, but 85%... Coronavirus COVID-19National-International-Beyond Johnson & Johnson Covid-19 Vaccine: 66% Effective in Global Trial, but 85% Against Severe Disease January 29, 2021 You are unauthorized to view this page. Username or E-mail Password Remember Me Forgot Password
